These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37968405)

  • 1. Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer.
    Zhou P; Shi H; Huang H; Sun X; Yuan S; Chapman NM; Connelly JP; Lim SA; Saravia J; Kc A; Pruett-Miller SM; Chi H
    Nature; 2023 Dec; 624(7990):154-163. PubMed ID: 37968405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single-Cell CRISPR Screen Reveals Intratumoral CD8+ T-cell Fate Regulomes.
    Cancer Discov; 2024 Jan; 14(1):17. PubMed ID: 38038494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential mechanisms of cancer stem-like progenitor T-cell bio-behaviours.
    Ni L
    Clin Transl Med; 2024 Aug; 14(8):e1817. PubMed ID: 39169517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modeling of CD8
    Wu JE; Manne S; Ngiow SF; Baxter AE; Huang H; Freilich E; Clark ML; Lee JH; Chen Z; Khan O; Staupe RP; Huang YJ; Shi J; Giles JR; Wherry EJ
    Sci Immunol; 2023 Aug; 8(86):eade3369. PubMed ID: 37595022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
    Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
    Front Immunol; 2022; 13():869768. PubMed ID: 35774790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.
    Chen Z; Ji Z; Ngiow SF; Manne S; Cai Z; Huang AC; Johnson J; Staupe RP; Bengsch B; Xu C; Yu S; Kurachi M; Herati RS; Vella LA; Baxter AE; Wu JE; Khan O; Beltra JC; Giles JR; Stelekati E; McLane LM; Lau CW; Yang X; Berger SL; Vahedi G; Ji H; Wherry EJ
    Immunity; 2019 Nov; 51(5):840-855.e5. PubMed ID: 31606264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progenitor-like exhausted SPRY1
    Liu Z; Zhang Y; Ma N; Yang Y; Ma Y; Wang F; Wang Y; Wei J; Chen H; Tartarone A; Velotta JB; Dayyani F; Gabriel E; Wakefield CJ; Kidane B; Carbonelli C; Long L; Liu Z; Su J; Li Z
    Cancer Cell; 2023 Nov; 41(11):1852-1870.e9. PubMed ID: 37832554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Dolina JS; Van Braeckel-Budimir N; Thomas GD; Salek-Ardakani S
    Front Immunol; 2021; 12():715234. PubMed ID: 34354714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.
    Yim S; Hwang W; Han N; Lee D
    Front Immunol; 2022; 13():884561. PubMed ID: 35651625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of terminally exhausted CD8
    Guo Y; Xie YQ; Gao M; Zhao Y; Franco F; Wenes M; Siddiqui I; Bevilacqua A; Wang H; Yang H; Feng B; Xie X; Sabatel CM; Tschumi B; Chaiboonchoe A; Wang Y; Li W; Xiao W; Held W; Romero P; Ho PC; Tang L
    Nat Immunol; 2021 Jun; 22(6):746-756. PubMed ID: 34031618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade.
    Tian W; Qin G; Jia M; Li W; Cai W; Wang H; Zhao Y; Bao X; Wei W; Zhang Y; Shao Q
    Front Immunol; 2023; 14():1198551. PubMed ID: 37398674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICOS limits memory-like properties and function of exhausted PD-1
    Humblin E; Korpas I; Prokhnevska N; Vaidya A; Lu J; van der Heide V; Filipescu D; Bobrowski T; Marks A; Park MD; Bernstein E; Brown BD; Lujambio A; Dominguez-Sola D; Rosenberg BR; Kamphorst AO
    bioRxiv; 2024 Sep; ():. PubMed ID: 39345453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1
    Humblin E; Korpas I; Lu J; Filipescu D; van der Heide V; Goldstein S; Vaidya A; Soares-Schanoski A; Casati B; Selvan ME; Gümüş ZH; Wieland A; Corrado M; Cohen-Gould L; Bernstein E; Homann D; Chipuk J; Kamphorst AO
    Sci Immunol; 2023 Aug; 8(86):eadg0878. PubMed ID: 37624910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T cells in distinct cellular niches.
    Dähling S; Mansilla AM; Knöpper K; Grafen A; Utzschneider DT; Ugur M; Whitney PG; Bachem A; Arampatzi P; Imdahl F; Kaisho T; Zehn D; Klauschen F; Garbi N; Kallies A; Saliba AE; Gasteiger G; Bedoui S; Kastenmüller W
    Immunity; 2022 Apr; 55(4):656-670.e8. PubMed ID: 35366396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Mass Cytometry to Profile Human T Cell Exhaustion.
    Winkler F; Bengsch B
    Front Immunol; 2019; 10():3039. PubMed ID: 32038613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB2 regulates the differentiation and stemness of exhausted CD8
    Neubert EN; DeRogatis JM; Lewis SA; Viramontes KM; Ortega P; Henriquez ML; Buisson R; Messaoudi I; Tinoco R
    Nat Commun; 2023 Sep; 14(1):5631. PubMed ID: 37704621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursor exhausted T cells: key to successful immunotherapy?
    Kallies A; Zehn D; Utzschneider DT
    Nat Rev Immunol; 2020 Feb; 20(2):128-136. PubMed ID: 31591533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8
    Baxter AE; Huang H; Giles JR; Chen Z; Wu JE; Drury S; Dalton K; Park SL; Torres L; Simone BW; Klapholz M; Ngiow SF; Freilich E; Manne S; Alcalde V; Ekshyyan V; Berger SL; Shi J; Jordan MS; Wherry EJ
    Immunity; 2023 Jun; 56(6):1320-1340.e10. PubMed ID: 37315535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective control of transposable element expression during T cell exhaustion and anti-PD-1 treatment.
    Bonté PE; Metoikidou C; Heurtebise-Chretien S; Arribas YA; Sutra Del Galy A; Ye M; Niborski LL; Zueva E; Piaggio E; Seguin-Givelet A; Girard N; Alanio C; Burbage M; Goudot C; Amigorena S
    Sci Immunol; 2023 Oct; 8(88):eadf8838. PubMed ID: 37889984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.